---
title: "UnitedHealth, CVS, Kaiser oppose Medicare plan to restrict remote patient monitoring vendors"
id: "stat-news-0-stat-unitedhealth-cvs-push-back-on-medicare-plan-to-curb-remote-patient"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-0-stat-unitedhealth-cvs-push-back-on-medicare-plan-to-curb-remote-patient"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/09/23/unitedhealth-cvs-pushback-medicare-plan-rpm-abuse/?utm_campaign=rss"
published_at: "2026-09-23T08:30:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# UnitedHealth, CVS, Kaiser oppose Medicare plan to restrict remote patient monitoring vendors
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-0-stat-unitedhealth-cvs-push-back-on-medicare-plan-to-curb-remote-patient
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/2026/09/23/unitedhealth-cvs-pushback-medicare-plan-rpm-abuse/?utm_campaign=rss)
- **Published At:** 2026-09-23T08:30:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Major integrated insurers — **UnitedHealth Group**, **CVS Health**, and **Kaiser Permanente** — submitted formal objections to a Centers for Medicare and Medicaid Services (CMS) proposal affecting remote patient monitoring (RPM). - The CMS proposal would require RPM services billed to Medicare be delivered by direct employees of the billing practice, which would effectively prohibit use of contractors or third‑party vendors for those services. - RPM uses connected devices such as blood pressure cuffs, scales, and blood glucose meters to monitor patients with chronic conditions including **hypertension**, **diabetes**, and **heart failure**. - The insurers argued for more targeted guardrails on RPM rather than a broad ban on vendor-contracted services; they favored focused regulation instead of the proposed employee-only mandate. - UnitedHealth’s pushback is notable because its insurer subsidiary, **UnitedHealthcare**, recently moved to stop paying for most RPM on the grounds of “insufficient evidence of efficacy.” - The reporting indicates the story is behind a STAT+ paywall; many specifics of CMS’s proposal, the insurers’ detailed arguments, and CMS’s response were not reported in the available source text. - Because the source is truncated and subscriber‑only beyond the excerpt, additional details such as exact regulatory language, timelines, and stakeholder responses were not provided in the accessible portion of the article. - The immediate implications raised include potential disruption to current RPM billing workflows and the operational model of providers that rely on vendor partners to deliver monitoring services. - The insurers involved operate both payer and care delivery businesses, which likely shapes their interest in preserving contractor-based RPM arrangements. - The source did not report outcomes of any public comment process, next regulatory steps, or final CMS decisions within the available excerpt.
## Clinical Analysis & Structured Key Points
[Skip to Main Content](https://www.statnews.com/2026/09/23/unitedhealth-cvs-pushback-medicare-plan-rpm-abuse/?utm_campaign=rss#wrapper) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-white.svg) ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/09/23/unitedhealth-cvs-pushback-medicare-plan-rpm-abuse/?utm_campaign=rss) [Cancer](https://www.statnews.com/topic/cancer/) [FDA](https://www.statnews.com/topic/fda/) [research](https://www.statnews.com/topic/research/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) My Account * [Settings Complete your personal information for a more tailored experience ](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing](https://www.statnews.com/my-account/billing/) * [Log In](https://www.statnews.com/login/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) Reporting from the frontiers of health and medicine ](https://www.statnews.com/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Public Health](https://www.statnews.com/category/health/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Policy](https://www.statnews.com/category/politics/) * [Science](https://www.statnews.com/category/in-the-lab/) * [First Opinion](https://www.statnews.com/category/first-opinion/) * [STAT+](https://www.statnews.com/topic/stat-plus/) * [STAT Events](https://www.statnews.com/events/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Search * [Log In](https://www.statnews.com/login/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [My Account](https://www.statnews.com/my-account/) My Account * [Settings](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing History](https://www.statnews.com/my-account/billing/) [Home](https://www.statnews.com/) News * [Latest](https://www.statnews.com/latest/) * [Series & Investigations](https://www.statnews.com/stat-series-and-investigations-award-winning-journalism/) * Business * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Health Insurance](https://www.statnews.com/category/insurance/) * [Hospitals](https://www.statnews.com/category/hospitals/) * [Medical Devices](https://www.statnews.com/topic/medical-devices/) * Washington * [Policy](https://www.statnews.com/category/politics/) * [FDA](https://www.statnews.com/topic/fda/) * [NIH](https://www.statnews.com/topic/nih/) * Science * [CRISPR](https://www.statnews.com/topic/crispr/) * [Gene Therapy](https://www.statnews.com/topic/gene-therapy/) * [Neuroscience](https://www.statnews.com/topic/neuroscience/) * Public Health * [Addiction](https://www.statnews.com/topic/addiction/) * [Covid-19](https://www.statnews.com/topic/coronavirus/) * [Abortion](https://www.statnews.com/topic/abortion/) * [Health Disparities](https://www.statnews.com/topic/health-disparities/) * [Infectious Disease](https://www.statnews.com/topic/infectious-disease/) * [Mental Health](https://www.statnews.com/topic/mental-health/) * Disease * [Cancer](https://www.statnews.com/topic/cancer/) * [Cardiovascular Disease](https://www.statnews.com/topic/cardiovascular-disease/) * [Chronic Disease](https://www.statnews.com/topic/chronic-disease/) * [Diabetes](https://www.statnews.com/topic/diabetes/) * [Alzheimer's](https://www.statnews.com/topic/alzheimers/) * [Obesity](https://www.statnews.com/topic/obesity/) * Features * [Health Care Costs](https://www.statnews.com/health-insurance-costs-out-of-pocket-out-of-reach-series/) * [The Deadliest Drug](https://www.statnews.com/alcohol-epidemic-hiding-plain-sight-deadliest-drug-series/) * [Science, Shattered](https://www.statnews.com/american-science-shattered/) [Newsletters](https://www.statnews.com/signup/) [Opinion](https://www.statnews.com/category/first-opinion/) Columns * [Adam Feuerstein](https://www.statnews.com/category/adams-take/) * [Matthew Herper](https://www.statnews.com/category/matts-take/) * [Ed Silverman](https://www.statnews.com/category/pharmalot-view/) [Reports](https://reports.statnews.com/) [E-books](https://www.statnews.com/ebooks/) [Podcasts](https://www.statnews.com/podcasts/) [Tools & Trackers](https://www.statnews.com/trackers/) * [CRISPR Tracker](https://www.statnews.com/feature/crispr/tracker/) * [Breakthrough Device Tracker](https://www.statnews.com/feature/stat-plus/breakthrough-device-designation-fda-tracker/) * [Generative AI Tracker](https://www.statnews.com/feature/stat-plus/generative-ai-health-hospitals-tracker/) * [Obesity Drug Tracker](https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/) [Events](https://www.statnews.com/events/) * [Upcoming Events](https://www.statnews.com/events#upcoming-events) * [Summits](https://www.statnews.com/stat-summits/) [Community](https://www.statnews.com/community/) * [STAT Wunderkinds 2026](https://www.statnews.com/wunderkinds-nominate/) [Video](https://youtube.com/@Statnews) [Advertise](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com/) What's the word? Test your knowledge with our new weekday mini crossword [ Start solving ](https://www.statnews.com/stat-mini-crossword/) [STAT Plus](https://www.statnews.com/stat-plus/)[Health tech](https://www.statnews.com/category/health-tech/) # UnitedHealth, CVS push back on Medicare plan to curb remote patient monitoring ## The insurers call for focused guardrails on RPM instead of a ban on vendors * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/09/23/unitedhealth-cvs-pushback-medicare-plan-rpm-abuse/?utm_campaign=rss) ![](https://www.statnews.com/wp-content/uploads/2026/09/AdobeStock_404249326-645x645.jpeg) Adobe ![](https://www.statnews.com/wp-content/uploads/2021/02/mario-a-avatar-small-80x80.png) By [Mario Aguilar](https://www.statnews.com/staff/mario-aguilar/) Sept. 23, 2026 Health Tech Correspondent ![](https://www.statnews.com/wp-content/uploads/2021/02/mario-a-avatar-small-80x80.png) [Mario Aguilar](https://www.statnews.com/staff/mario-aguilar/) 1. [](https://www.linkedin.com/in/mario-aguilar-13361235/ "Linkedin") 2. [](https://x.com/mariojoze "X") mario.aguilar@statnews.com Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer wearables. He’s also the co-author of the free, twice weekly [STAT Health Tech newsletter](https://www.statnews.com/signup/health-tech/). You can reach Mario on Signal at mariojoze.13. Major insurers are pushing back on a Medicare proposal that would significantly disrupt how many doctors bill for tracking the health of patients using devices like connected blood pressure cuffs, scales, and blood glucose meters. These remote monitoring services help patients manage a range of medical conditions, including hypertension, diabetes, and heart failure. UnitedHealth Group, CVS Health, and Kaiser Permanente all wrote letters to the Centers for Medicare and Medicaid Services opposing a proposal that would require that remote patient monitoring care be delivered by direct employees of the practice that is billing for them — effectively banning providers from using contractors for the care. All of these groups operate both insurers and care organizations. Advertisement The opposition from UnitedHealth Group is notable in particular because the company’s insurance subsidiary, UnitedHealthcare, recently [attempted to stop paying for most remote patient monitoring](https://www.statnews.com/2025/11/07/united-healthcare-remote-patient-monitoring-medicare-advantage/) “due to insufficient evidence of efficacy.” STAT+ Exclusive Story Already have an account? [Log in](https://www.statnews.com/login/) ![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-breaker-bg.png) [ ![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo-white.svg) ](https://www.statnews.com/stat-plus/) ## This article is exclusive to STAT+ subscribers ### Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+. Already have an account? [Log in](https://www.statnews.com/login/) Individual plans Group plans Monthly $39 Totals $468 per year [$39/month](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-monthly-39-0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-monthly-39-0) Totals $468 per year Starter $30 for 3 months, then $399/year [$30 for 3 months](https://www.statnews.com/stat-plus/subscribe/?plan=3mo30_yearly_pw) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=3mo30_yearly_pw) Then $399/year Annual $399 Save 15% [$399/year](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-annually-399-0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-annually-399-0) Save 15% 11+ Users Custom Savings start at 25%! [Request A Quote](https://www.statnews.com/stat-plus/group-subscriptions/) [Request A Quote](https://www.statnews.com/stat-plus/group-subscriptions/) Savings start at 25%! 2-10 Users $300 Annually per user [$300/year](https://www.statnews.com/stat-plus/subscribe/?plan=stat_plus_groups_self_serve_0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat_plus_groups_self_serve_0) $300 Annually per user [View All Plans](https://www.statnews.com/stat-plus/) [![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo.svg)](https://www.statnews.com/stat-plus/) To read the rest of this story subscribe to STAT+. [Subscribe](https://www.statnews.com/stat-plus/) [Log In](https://www.statnews.com/login/) [health tech](https://www.statnews.com/topic/health-tech/), [Medicare](https://www.statnews.com/topic/medicare/), [Policy](https://www.statnews.com/topic/policy/), [STAT+](https://www.statnews.com/topic/stat-plus/) [Submit a correction request](https://www.statnews.com/contact/?how_can_we_help_=Editorial%20Correction%20Request)[Reprints](https://www.parsintl.com/publications/stat/) 1. ![](https://www.statnews.com/wp-content/uploads/2021/02/mario-a-avatar-small-80x80.png) [Mario Aguilar](https://www.statnews.com/staff/mario-aguilar/) 1. [](https://x.com/mariojoze "X") 2. 3. [](https://www.linkedin.com/in/mario-aguilar-13361235/ "Linkedin") Health Tech Correspondent 1. [](https://x.com/mariojoze "X") 2. 3. [](https://www.linkedin.com/in/mario-aguilar-13361235/ "Linkedin") Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer wearables. He’s also the co-author of the free, twice weekly [STAT Health Tech newsletter](https://www.statnews.com/signup/health-tech/). You can reach Mario on Signal at mariojoze.13. ![](https://www.statnews.com/wp-content/themes/stat/images/article-new/envelope-open.svg) ![](https://www.statnews.com/wp-content/uploads/2023/06/Health-Tech-Logo-Black-640x235.png) ### Newsletter Tech is transforming health care and life sciences. Our original reporting is here to keep you ahead of the curve. Please enter a valid email address. Sign Up Your data will be processed in accordance with our [Privacy Policy](https://www.statnews.com/privacy/) and [Terms of Service](https://www.statnews.com/terms-conditions/). You may opt out of receiving STAT communications at any time. Advertisement Most Popular 1. ![](https://www.statnews.com/wp-content/uploads/2018/05/GettyImages-115791062-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [HHS unveils new initiatives to reduce animal testing in drug development](https://www.statnews.com/pharmalot/2026/09/22/hhs-initiatives-reduce-animal-testing-in-drug-development/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/09/alkermes-900-winter-st-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Alkermes’ orexin agonist shows potential to treat ADHD in early-stage trial](https://www.statnews.com/2026/09/21/alkermes-orexin-agonist-adhd-study/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/09/Dosing-Room-Layout-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Definium’s LSD therapy eased anxiety in second large trial](https://www.statnews.com/2026/09/14/definiums-lsd-therapy-eased-anxiety-large-trial-psychedelic/) 4. ![](https://www.statnews.com/wp-content/uploads/2025/04/AdobeStock_1068642359_Editorial_Use_Only-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Novo may be getting a better deal than expected with Medicare’s Bridge program](https://www.statnews.com/2026/09/22/biotech-news-novo-may-be-getting-a-better-deal-than-expected-with-medicare-bridge/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/02/AdobeStock_607424496-80x80.jpeg) [How AI is making me a better clinical psychologist](https://www.statnews.com/2026/02/11/ai-therapist-consultant-psychologist/) #### [ Reports ](https://reports.statnews.com/) [ ![](https://www.statnews.com/wp-content/uploads/2026/08/2026_CancerReport_ReportCover-328x424.jpg) Explore Cancer’s transformational moments: KRAS, CAR-T, immunotherapy, and more ](https://reports.statnews.com/products/cancer-transformational-moments-advances-in-kras-car-t-immunotherapy) Advertisement #### [Events](https://www.statnews.com/events/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/924_Samsung_VirtualEvent_Wordpress_FeaturedImage-80x80.jpg) Biosimilars: Have We Reached an Inflection Point? Virtual Sep 24 ](https://www.statnews.com/event/biosimilars-what-is-next-virtual-event-sept-2026/) [ ![](https://www.statnews.com/wp-content/uploads/2026/01/Flagship2026_Wordpress_CalendarImageRegGoLive-1-80x80.jpg) 2026 STAT Summit Boston, MA Oct 14 ](https://www.statnews.com/event/2026-stat-summit/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/2026_DD_OfficeHours_VirtualEvent_Wordpress_CalendarImage-80x80.jpg) Office Hours with Isabella Cueto and Lev Facher Virtual Jul 29 ](https://www.statnews.com/event/deadliest-drug-series-office-hours-ama-july-2026/) Most Read in [STAT+](https://www.statnews.com/stat-plus/) 1. ![](https://www.statnews.com/wp-content/uploads/2025/12/AdobeStock_288008063-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Vera kidney drug Trutakna shows strong final results in Phase 3 trial](https://www.statnews.com/2026/09/15/vera-kidney-drug-trutakna-shows-strong-phase-3-results-igan/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/09/Eliza-treated-with-Gene-therapy-2016-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease](https://www.statnews.com/2026/09/17/sanfilippo-syndrome-treatment-ultragenyx-approval/) 3. ![](https://www.statnews.com/wp-content/uploads/2022/06/AdamsTake_Illustration_MollyFerguson_061322-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [A Sellas immunotherapy study, long delayed, will end in failure](https://www.statnews.com/2026/09/17/sellas-immunotherapy-study-acute-myeloid-leukemia/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/09/AP6802385202387510-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [What a vote on Grail’s cancer detection test could mean for the company, patients, and regulators](https://www.statnews.com/2026/09/21/grail-galleri-fda-advisory-committee-meeting-documents/) 5. ![](https://www.statnews.com/wp-content/uploads/2025/12/AdobeStock_1649079417-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [A biotech hedge fund births a new immunology company ](https://www.statnews.com/2026/09/17/biotech-hedge-fund-startup-north-immunology/) #### Recommended ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Business Business September 18, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Trump touts pharma deals to offer cheaper drugs to state Medicaid programs ](https://www.statnews.com/2026/09/18/trump-touts-state-participation-generous-medicaid-drug-discount-program/) By [John Wilkerson](https://www.statnews.com/staff/john-wilkerson/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Insurance Insurance September 18, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: In a fight over denied claims, HCA sues out-of-state Blue Cross Blue Shield plan ](https://www.statnews.com/2026/09/18/hca-hospitals-sue-independence-blue-cross-prior-authorization/) By [Bob Herman](https://www.statnews.com/staff/bob-herman/) Advertisement ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Health Health September 17, 2026 ### [ Kennedy moves to revive preventive services panel with new members, after months of vacancies ](https://www.statnews.com/2026/09/17/kennedy-names-eight-new-members-uspstf-task-force/) By [Chelsea Cirruzzo](https://www.statnews.com/staff/chelsea-cirruzzo/), [Elizabeth Cooney](https://www.statnews.com/staff/elizabeth-cooney/), and [Sarah Todd](https://www.statnews.com/staff/sarah-todd/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) D.C. Diagnosis D.C. Diagnosis September 17, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: FDA has too few staffers to hire more staff ](https://www.statnews.com/2026/09/17/fda-hiring-bottleneck-senate-hearings-chris-klomp-nicole-saphier/) By [John Wilkerson](https://www.statnews.com/staff/john-wilkerson/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Business Business September 16, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: GOP aims to change Medicare adviser’s math so it’s more favorable to health insurers ](https://www.statnews.com/2026/09/16/medicare-advantage-overpayments-analysis-medpac-change-apples-to-apples-act/) By [John Wilkerson](https://www.statnews.com/staff/john-wilkerson/) #### Subscriber Picks 1. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: A Sellas immunotherapy study, long delayed, will end in failure ](htt
## Related Clinical Research

- [Medicare expands ACCESS pilot to cover more chronic conditions and lists 39 providers](https://medichelpline.com/clinical-feed/stat-news-1-stat-medicare-to-expand-its-pilot-that-pays-for-technology-to-manage-chronic.md)
- [Definium Therapeutics reports Phase 3 LSD pill DT120 reduced anxiety in generalized anxiety disord](https://medichelpline.com/clinical-feed/stat-news-1-stat-definium-therapeutics-says-its-lsd-therapy-eased-anxiety-in-late-stage.md)
- [Impact of Nighttime Light Exposure on Heart Health and Disease Risk](https://medichelpline.com/clinical-feed/medical-news-today-0-nighttime-light-exposure-may-alter-the-heart-and-increase-disease-risk.md)
- [Intensive blood pressure control linked to 15% lower 7-year dementia risk](https://medichelpline.com/clinical-feed/medical-news-today-0-intensive-blood-pressure-control-cuts-7-year-dementia-risk-by-15-study-finds.md)
- [Cardiac-targeted delivery strategies for advanced therapies in heart disease](https://medichelpline.com/clinical-feed/pubmed-42284133.md) (DOI: 10.1093/eurheartj/ehag432)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.